The Antimicrobial Drugs Advisory Committee, which advises the U.S. Food and Drug Administration, meets at 9 a.m. ET on March 16 to discuss a new application for Pfizer’s Paxlovid pill for oral use. The pill treats mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID 19, including hospitalization or death….
Japan’s Shionogi Says COVID-19 Pill Shows Rapid Clearance of Virus
TOKYO—An experimental treatment from Shionogi & Co. Ltd. has shown rapid clearance of the virus that causes COVID-19, according to new data, the Japanese drug maker said on Sunday. The pill, S-217622, “demonstrated rapid clearance of the infectious SARS-CoV-2 virus”, Shionogi said in a statement, citing Phase-2b results from the Phase II/III clinical trial of…
Merck Sees 2022 Sales up Nearly 20 Percent, Mostly on New COVID Pill
Merck & Co said on Wednesday it expects its 2022 sales to increase as much as 18 percent over last year, mostly on sales of its new COVID-19 pill, molnupiravir. The drugmaker said sales of the COVID-19 drug were $952 million in the fourth quarter, and it expects another $5 billion to $6 billion in…
Merck Authorizes Indian Pharma Company to Manufacture and Supply Affordable COVID-19 Pills
Indian multinational pharmaceutical company, Dr. Reddy’s Laboratories will be launching a generic version of Merck’s COVID-19 oral antiviral medication, molnupiravir, at an extremely affordable treatment rate of 1,400 Rupees ($18.8), 37 times cheaper than in the United States. Dr. Reddy’s “Motflu” will be priced at $0.47 per 200-mg pill, and a treatment consists of a…
Vietnam Says Pfizer, MSD to Grant Its Firms Licenses to Produce COVID-19 Pills
HANOI—Drugmakers Pfizer Inc and MSD, known as Merck & Co Inc in North America, have agreed to give licenses to firms in Vietnam to produce COVID-19 treatment pills, Vietnam’s ministry of health said on Friday. The companies have sent letters of approval to the Drug Administration of Vietnam, the ministry said in a statement, for…
The Race Between COVID-19 Pills and Vaccines
News analysis Last week, Pfizer asked the Food and Drug Administration (FDA) to authorize its experimental antiviral pill for COVID-19. Merck’s COVID-19 antiviral pill has already been approved by Britain’s Medicines and Healthcare products Regularly Agency (MHRA), and the company has also applied for approval with the FDA. With a pandemic that has already killed more…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`